Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Diagnostics

Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.

Clarity Pharmaceuticals on LinkedIn: Clarity and Evergreen expand Targeted Copper Theranostics manufacturing -…

Clarity Pharmaceuticals on LinkedIn: Radiopharmaceuticals Expert Joins Clarity as Chief Scientific Officer -…

First Participant Treated Using NorthStar Medical Radioisotopes' Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals' Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma

Pharmaceutical Company Developing Radiopharmaceuticals

Bringing Clarity To Radiopharmaceuticals, PDF, Positron Emission Tomography

Investor Centre - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

Clarity Pharmaceuticals on LinkedIn: First participant treated in the highest dose cohort of neuroblastoma…

Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Diagnostics

Clarity Pharmaceuticals to Begin Phase 3 Trial for New PSMA PET Agent for Prostate Cancer

Clarity Pharmaceuticals